Zoldonrasib plus daraxonrasib targets KRAS G12D in metastatic pancreatic cancer with promising early results

Therapeutic mammoplasty: An advanced oncoplastic breast surgery technique

ASCO 2026: Highlights and analysis

ASCO 2026: Latest in prostate cancer

Early-onset gastrointestinal cancers show more advanced disease and wider racial survival gaps

Tarlatamab improves brain metastases control and survival compared to chemo in SCLC

Daraxonrasib nearly doubles survival in previously treated metastatic pancreatic cancer

ASCO 2026: Latest updates in mRCC

Daraxonrasib plus chemotherapy shows promising first-line activity in RAS-mutant metastatic pancreatic cancer

Enfortumab vedotin and pembrolizumab improves EFS, OS, and pCR in muscle-invasive bladder cancer

AI and pathology reveal higher late recurrence risk in invasive lobular breast cancer

Tarlatamab improves symptoms and QoL over chemo in previously treated SCLC